Albuterol/Levalbuterol top July drug price changes

Why This Topic Matters

Quarterly ASP updates can materially affect reimbursement for frequently administered drugs, especially in practices that bill these products often. Understanding which drug codes were added, replaced, or repriced helps organizations monitor revenue impact and stay current with Medicare payment changes.

Article Sections

1. CMS July ASP update overview

   Summarizes the quarterly Part B drug pricing update and the general pattern of payment changes across the drug list. Provides context for the effective period and the broader scope of the update.

2. Albuterol and Levalbuterol payment changes

   Discusses the major pricing shifts affecting the bronchodilator products that anchor the article. Covers the transition from earlier coding to updated Q codes and the impact on commonly billed forms.

3. Other high-impact drug price increases

   Lists additional frequently billed drugs with notable payment increases in the quarterly update. Highlights the range of drug categories represented among the largest positive changes.

4. Other high-impact drug price decreases

   Lists additional frequently billed drugs with notable payment decreases in the quarterly update. Includes several drug categories that experienced substantial reductions during the same period.

5. Source and methodology note

   Identifies the data source used for the analysis and the basis for ranking the drugs. Notes the reporting period covered by the price list.